Benoit, Yves

Bertrand, Y

Cave, H

Chantrain, C

Clappier, E

Costa, V

Dastugue, N

Dresse, M-F

Drunat, S

Ferster, A

Freycon, C

Gilotay, C

Girard, S

Grardel, N

Lutz, P

Mazingue, F

Millot, F

Minckes, O

Norga, K

Piette, C

Plat, G

Pluchart, C

Poiree, M

Rohrlich, P-S

Simon, P

Sirvent, N

Suciu, S

Uyttebroeck, A

van der Werff ten Bosch, J

Van Roy, Nadine

Yakouben, K

peer reviewedIn childhood B-cell precursor acute lymphoblastic leukaemias (BCP-ALL), the presence of an ETV6-RUNX1 fusion transcript defines one of the most prevalent genetic subgroups, together with the high hyperdiploidy (HeH) ALL. Although ETV6-RUNX1pos ALLs are associated with favourable outcome, their proper treatment strategies remain debatable, some groups suggesting crucial impact of upfront intensive treatment while others favour low-intensity antimetabolite-based therapy

Piette, Caroline

Yacouben, K

Van  Roy, N

Poirée, M

Dresse, Marie-Françoise

van der Werff Ten Bosch, J

Rohrlich, PS

Benoit, Y

Cavé, H

Open Repository and Bibliography - Liège

Leukemia

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials

Drunat, Séverine

Yakouben, Karima

Dastugue, Nicole

Grardel, Nathalie

van Roy, N

Uyttebroeck, Anne

Minckes, Odile

Sirvent, Nicolas

Ferster, Alina

Poirée, Marilyne

Millot, Frédéric

van der Werff Ten Bosch, Jutte

Gilotay, C.

Benoît, Yves

DI-fusion

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials.

Piette, C.

Suciu, S.

Clappier, E.

Bertrand, Y.

Drunat, S.

Girard, S.

Yakouben, K.

Plat, G.

Dastugue, N.

Mazingue, F.

Grardel, N.

van Roy, N.

Uyttebroeck, A.

Costa, V.

Minckes, O.

Sirvent, N.

Simon, P.

Lutz, P.

Ferster, A.

Pluchart, C.

Poiree, M.

Freycon, C.

Millot, F.

Chantrain, C.

van der ten Bosch, J. Werff

Norga, Koenraad

Benoit, Y.

Cave, H.

Institutional Repository Universiteit Antwerpen

SCOPUS: le.jinfo:eu-repo/semantics/publishe

Mazingue, Françoise

Costa, Vitor

Simon, Pauline

Lutz, Patrick

Suciu, Stefan

Pluchart, Claire

Freycon, Claire

Chantrain, Christophe

Norga, Koen

Gilotay, Caroline

Rohrlich, Pierre

Clappier, Emmanuelle

Cavé, Hélène

Bertrand, Yves

Girard, Sandrine

Plat, Geneviève

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: Results of the EORTC CLG 58881 and 58951 trials

Ghent University Academic Bibliography

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials

C Piette

S Suciu

E Clappier

Y Bertrand

S Drunat

S Girard

K Yakouben

G Plat

N Dastugue

F Mazingue

N Grardel

N van Roy

A Uyttebroeck

V Costa

O Minckes

N Sirvent

P Simon

P Lutz

A Ferster

C Pluchart

M Poirée

C Freycon

M-F Dresse

F Millot

C Chantrain

J van der Werff ten Bosch

K Norga

C Gilotay

P-S Rohrlich

Y Benoit

H Cavé

Crossref

http://orbi.ulg.ac.be/bitstream/2268/217507/1/Manuscript_Leukemia_2017_ETV6-RUNX1.pdf

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials

Abstract

Similar works

Full text

Available Versions

Open Repository and Bibliography - Liège

DI-fusion

Institutional Repository Universiteit Antwerpen

DI-fusion

Ghent University Academic Bibliography

Crossref